Tenshi Kaizen (TK) is focussed on delivering advanced finished dosage products driven by proprietary technology platforms, global infrastructure, and a robust quality system. Our strategy is aligned with the founder’s ethos of producing reliable and cost-effective pharmaceuticals with speed and agility. As of today, Tenshi Kaizen has investments in three proprietary technology platforms viz. InstaPillTM technology for rapid dissolve tabs, the world’s first thermostable probiotics platform (Under Triphase) , and proprietary technology to extract and develop highly bioavailable natural products (Under Olene Life Sciences)
Building on our strong global network, we are committed to fulfilling the demands of the world markets by anticipating the future needs and pioneering strategic new in-roads into the commercial pharmaceutical sector.
Our eco-system is driven by 3 imperatives -
It underscores our responsibility and accountability to protect, sustain and grow our contribution towards environment, health, employee wellness and customer satisfaction with the highest levels of transparency.
Our people embody the skill, intelligence, dedication and thirst for research that medical innovation requires. Our open workplace policy encourages ideas, offers autonomy, nurtures leaders and rewards excellence.
To push the boundaries of science to deliver reliable and valuable pharmaceutical products that enhance the quality of lives, today and in the future.
To foster a productive and conducive environment for all our employees, encouraging innovation and creativity.
To keep up with the fast-paced dynamics of medical technology by staying a committed investor to innovation and breakthrough technology.
With acute attention to details and an adherence to perfection, we commit to produce superior quality and cost-effective products for various niche segments with speed and agility.
We strive for total corporate responsibility, strict regulatory compliance and environment protection.